Martin Fan

Stock Analyst at Wedbush

(4.87)
# 64
Out of 5,150 analysts
19
Total ratings
77.78%
Success rate
60.84%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Martin Fan

Zura Bio
Feb 9, 2026
Initiates: Outperform
Price Target: $15
Current: $6.49
Upside: +131.12%
Oruka Therapeutics
Jan 13, 2026
Maintains: Outperform
Price Target: $42$45
Current: $32.84
Upside: +37.03%
Zenas BioPharma
Dec 22, 2025
Reiterates: Outperform
Price Target: $45
Current: $25.18
Upside: +78.71%
Vor Biopharma
Nov 25, 2025
Assumes: Neutral
Price Target: $9
Current: $14.95
Upside: -39.80%
ImageneBio
Nov 25, 2025
Assumes: Underperform
Price Target: $2
Current: $6.13
Upside: -67.37%
AnaptysBio
Nov 24, 2025
Reiterates: Outperform
Price Target: $50
Current: $52.83
Upside: -5.36%
Sana Biotechnology
Nov 7, 2025
Maintains: Outperform
Price Target: $5$6
Current: $3.93
Upside: +52.67%
Artiva Biotherapeutics
Oct 17, 2025
Maintains: Outperform
Price Target: $18$23
Current: $5.47
Upside: +320.48%
Cartesian Therapeutics
Jul 9, 2025
Initiates: Outperform
Price Target: $38
Current: $7.48
Upside: +408.02%
Aclaris Therapeutics
May 28, 2025
Initiates: Outperform
Price Target: $8
Current: $3.04
Upside: +163.16%